SCHEMBL14228166

SCHEMBL14228166

N#C/N=C1\C=C(Oc2cc(C(F)(F)F)cc(C(F)(F)F)c2)/C(=N/C#N)C=C1Oc1cccc(C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ POLB P06746 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.40
▸ RECQL P46063 1/20 0.38
▸ ABCG2 Q9UNQ0 1/20 0.38
▸ LRRK2 Q5S007 1/20 0.38
▸ ADORA2A P29274 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ LTA4H P09960 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ KIF11 P52732 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PPARG P37231 2/20 0.35
▸ PPARA Q07869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14228162 0.96 POLB (0.44) L3MBTL1CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL14228161 0.90 LMNA (0.31) L3MBTL1CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL13879220 0.78 POLB (0.42) L3MBTL1CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL13879153 0.78 KIF11 (0.37) L3MBTL1ALDH1A1LTA4HKIF11KDM4E
SCHEMBL16772102 0.78 POLB (0.41) L3MBTL1CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL13879310 0.76 KIF11 (0.45) L3MBTL1CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL14228135 0.74 POLB (0.43) L3MBTL1CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL14014018 0.74 LTA4H (0.44) L3MBTL1CYP1A2CYP2C9CYP2C19POLB
SCHEMBL13879213 0.73 L3MBTL1 (0.44) L3MBTL1CYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL9798371 0.72 LTA4H (0.54) L3MBTL1CYP1A2CYP2C9CYP2C19NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080093985-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080093985-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME NDUFS7, NDUFA9, NDUFS8 L3MBTL1 1162/4885CYP1A2 854/4885CYP2C9 235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback